Cargando...

Cardiac Resynchronization—A Heart Failure Perspective

Over the past 15–20 years the development of new heart failure pharmacologic therapy has lowered mortality by 30–40% for this serious and prevalent clinical syndrome, within clinical trials conducted in patients with a dilated cardiomyopathy phenotype. However, over the past 5 years progress in the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Noninvasive Electrocardiol
Main Authors: Rivera, Dee Ann, Bristow, Michael R.
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing, Inc. 2005
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6932049/
https://ncbi.nlm.nih.gov/pubmed/16274412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1542-474X.2005.00076.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!